Insights

Rapamycin, an FDA-approved drug, extends lifespan in mammals by suppressing cancer. It also shows symptomatic benefits for aging traits like cognitive decline, suggesting it primarily targets aging mechanisms through cancer prevention.

Area of Science:

  • Gerontology
  • Pharmacology
  • Molecular Biology

Background:

  • Rapamycin is an FDA-approved compound that extends lifespan in mammals.
  • A key question is whether rapamycin slows aging or primarily extends longevity by inhibiting cancer, a major cause of death in mice.

Purpose of the Study:

  • To review the effects of pharmacological or genetic mammalian target of rapamycin (mTOR) inhibition on aging and longevity in mammals.
  • To evaluate current evidence regarding rapamycin's mechanism of lifespan extension.

Main Methods:

  • Literature review of studies on rapamycin and mTOR inhibition in mammals.
  • Analysis of evidence linking rapamycin's effects to aging processes and cancer suppression.

Main Results:

  • Current evidence suggests rapamycin extends lifespan mainly by suppressing cancers.
  • Rapamycin also demonstrates symptomatic effects on aging traits, including age-related cognitive impairments.

Conclusions:

  • Rapamycin's primary mechanism for lifespan extension in mammals appears to be cancer suppression.
  • The drug also offers symptomatic benefits for certain aging-related conditions.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.0K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.1K